Search

everythinglearnresearchcommunity

for

Search:↓

Androgens can cause hair growth in some areas and hair loss on the scalp.

Hormonal therapies are safe and effective for treating adult women's acne.

Androgens can cause hair growth in some areas but hair loss on the scalp.

Extracellular vesicles may effectively treat hair loss with minimal side effects.

Hormonal imbalances are a key cause of missed menstrual periods in women.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

Hair growth dysfunction involves various conditions with limited treatment options.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Oral contraceptives may cause hair loss in women.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Most skin changes during pregnancy are harmless and temporary, but some can risk the fetus and need careful treatment.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

Hair transplantation is the only permanent solution for female pattern hair loss and can greatly improve quality of life with careful planning.

Accurate diagnosis and timely, tailored treatments improve outcomes in obstetrics and gynecology.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Continuous light exposure in rats leads to PCOS-like symptoms and suggests sleep habits might affect the disorder's development.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

People with alopecia have a higher risk of thyroid cancer.

The conclusion is that recognizing hair growth cycles can improve the precision of dietary and health assessments from hair analysis.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

The document concludes that correct diagnosis of alopecia types is crucial, scalp biopsies are important, and more research is needed.

Hormonal therapies help treat female hair loss, but results are slow and vary.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.